Modra Pharmaceuticals Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $3.18M
Latest Deal Amount
  • Investors
  • 2

Modra Pharmaceuticals General Information

Description

Developer of an oral formulation technology designed to improve the delivery and bioavailability of chemotherapies. The company's technology includes oral formulations of anticancer drugs like docetaxel, paclitaxel, capecitabine, and thiosulfate after conducting various pre-clinical and clinical researches, enabling healthcare providers to cure patients suffering from cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Barbara Strozzilaan 201
  • 1083 HN Amsterdam
  • Netherlands
+31 020 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Modra Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 19-Dec-2018 $3.18M 00000 Completed Generating Revenue
2. Later Stage VC 01-Apr-2016 00000 Completed Generating Revenue
1. Debt - General 01-Jan-2010 $652K $652K Completed Startup
To view Modra Pharmaceuticals’s complete valuation and funding history, request access »

Modra Pharmaceuticals Executive Team (4)

Name Title Board Seat Contact Info
Chris Huiskamp Chief Financial Officer
Jan Schellens Ph.D Co-Founder, Chief Medical Officer and Strategic Medical Advisor
Colin Freund Co - Founder, Chief Executive Officer and Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Modra Pharmaceuticals Board Members (10)

Name Representing Role Since
Alan Barge Aglaia Oncology Funds Co-Chairman 000 0000
Anton Berns Ph.D Self Supervisory Board Member 000 0000
Colin Freund Self Co - Founder, Chief Executive Officer and Board Member 000 0000
Harry Büller MD Modra Pharmaceuticals Supervisory Board Member 000 0000
Hemanshu Shah Ph.D Self Co-Chairman 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Modra Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Modra Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Rijksdienst voor Ondernemend Nederland Lender/Debt Provider 000 0000 000000 0
Aglaia Oncology Funds Venture Capital Minority 000 0000 000000 0
To view Modra Pharmaceuticals’s complete investors history, request access »